Cord Blood Stem Cells Information - Mesenchymal Stem Cells News

Mesenchymal Stem Cells News

Stem cell study tackles potential complications of major surgeries Tuesday, September 30, 2008 @ 3:03PMResearchers at Intermountain Medical Center have launched a safety study of an investigational adult stem cell treatment that may repair kidney damage suffered during heart surgery.
NASA Spaceline Current Awareness 29 August 2008 Thursday, September 25, 2008 @ 3:27PMNASA Spaceline Current Awareness 29 August 2008
Therapy extends life in rats with nerve disease Monday, September 22, 2008 @ 8:52PM Treatment with genetically modified stem cells helped rats with a paralyzing disease live significantly longer, U.S. researchers said on Monday in a finding that could one day help humans.
Invitrogen Launches Stem Cell Culture Services Monday, September 22, 2008 @ 3:58PMInvitrogen Corporation (NASDAQ:IVGN), a provider of technologies for research, production and diagnostics, has introduced its custom PD-Direct(R) Bioprocess Services optimized for clinically compliant stem cell culture systems. This service will help stem cell therapy developers reduce risks through serum-free production systems, improve manufacturing productivity, and provide on-demand ...
Invitrogen Launches Stem Cell Culture Services Monday, September 22, 2008 @ 3:40PM CARLSBAD, Calif.----Invitrogen Corporation , a provider of technologies for research, production and diagnostics, has introduced its custom PD-Direct® Bioprocess Services optimized for clinically compliant stem cell culture systems.
Can Vibrating Platform Jiggle Fat Away? Monday, September 22, 2008 @ 3:09PMDoctors are seeing if standing on a vibrating platform can help patients lose fat and gain bone.
Cardiac Cell Transplant Studies Show Promise In Cardiac Tissue Repair Wednesday, September 3, 2008 @ 11:20AMTwo studies involving cardiac cell transplantation have shown an evolving role for bone marrow cells in cardiac cell therapy. The implantation of heart muscle cells and subsequent restoration of cardiac function was enhanced when bone marrow cells were implanted along with the cardiomyocytes. Researchers also found that mesenchymal stem cells derived from bone marrow provided an advantage over ...
Teeth Can Yield Stem Cells, Scientists Say Wednesday, August 27, 2008 @ 6:02PM Dental pulp from a wisdom tooth could be a new source of therapeutic stem cells, sidestepping the ethical concerns of embryonic cells, Japanese researchers claim.
Senior Staff Writer Friday, August 22, 2008 @ 8:04PMIn the early part of the 20th century, before the Depression and World War II, dozens of children lay comatose in hospital wards where hopeless families gathered awaiting their inevitable deaths.
Cell Transplants Protect Intestinal Tissue From Autoimmune Attack In Animal Model Friday, August 22, 2008 @ 6:13AMMassachusetts General Hospital (MGH) investigators have found that infusions of a particular bone marrow stem cell appeared to protect gastrointestinal tissue from autoimmune attack in a mouse model.
Stem cell cos could be allowed to go for phase-III trials: Dr Ramananda Nadig Thursday, August 21, 2008 @ 9:44PMGoing by the advanced research activities of stem cell companies and increasing evidence of Mesenchymal stem cell efficacy and safety to treat many of the life threatening conditions like spinal cord injury, myocardial infarction and leg ischemia in India, the Union ministry of health could permit phase-III safety and efficacy trials for this therapy.
Allogeneic, "Off-The-Shelf", Stem Cells Are Safe And Effective For Cervical Spine Fusion Thursday, August 21, 2008 @ 8:15AMAustralian regenerative medicine company Mesoblast Limited (ASX:MSB)(PINK:MBLTY), announced that its allogeneic, or "off-the-shelf", cell therapy product was safe and highly effective in preclinical trials for interbody fusion of the cervical spine in the neck.
Bone marrow stem cells may help control bowel disease Thursday, August 21, 2008 @ 4:51AMWashington, Aug 21 : Researchers have found that infusions of a particular bone marrow stem cell seem to protect gastrointestinal tissue from autoimmune attack in mice.
ArunA enters licensing pact with University of Georgia for human embryonic stem cell Thursday, August 21, 2008 @ 12:43AMArunA Biomedical, Inc, a leader in human embryonic stem cell derived products, announced that it has entered into an exclusive worldwide technology licensing agreement with the University of Georgia Research Foundation that will enable the company to commercialize human mesenchymal cells developed at the University of Georgia.
Bone marrow stem cells used to protect gastrointestinal tissue from autoimmune attack Wednesday, August 20, 2008 @ 9:27PMMassachusetts General Hospital (MGH) investigators have found that infusions of a particular bone marrow stem cell appeared to protect gastrointestinal tissue from autoimmune attack in a mouse model.
ArunA signs licensing agreement with University of Georgia Wednesday, August 20, 2008 @ 8:54PMArunA Biomedical has signed an exclusive worldwide technology licensing agreement with the University of Georgia Research Foundation that will enable the company to commercialize human mesenchymal cells developed at the University of Georgia.
ArunA Biomedical Announces Exclusive Worldwide Technology Licensing Agreement To Commercialize Human Embryonic Stem ... Tuesday, August 19, 2008 @ 7:02AMArunA Biomedical, Inc., a leader in human embryonic stem cell derived products, announced today that it has entered into an exclusive worldwide technology licensing agreement with the University of Georgia Research Foundation that will enable the company to commercialize human mesenchymal cells developed at the University of Georgia
Scientist uses stem cells to repair heart Thursday, August 14, 2008 @ 2:14AMDr. Joshua Hare believes medicine is close to a goal long thought to be impossible: healing the human heart.
Scientists use stem cells to repair human heart Tuesday, August 12, 2008 @ 10:36AMMIAMI -- Dr. Joshua Hare believes medicine is close to a goal long thought to be impossible: healing the human heart.
Qld begins clinical trials using adult stem cells Sunday, August 10, 2008 @ 4:02PMNew adult stem cell trials in Australia could mean fewer people needing organ transplants in the future.
Invitrogen Licenses Stem Cell Line From Buck Institute Thursday, July 31, 2008 @ 11:01AMInvitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, has licensed an engineered stem cell line from the Buck Institute for Age Research
Stem cell therapy plan for placentas Wednesday, July 23, 2008 @ 9:28AMSTEM cells would be harvested from the placentas and umbilical cords of newborn babies, under a plan Australian researchers say could yield therapies for conditions ranging from arthritis to burns.
Stem Cell Therapy For Dogs Tuesday, July 22, 2008 @ 2:01PMA new stem cell therapy is giving relief to dogs and could soon help people suffering from chronic pain. VIDEO: Stem Cell Therapy For Dogs
Human blood vessels grown in lab Friday, July 18, 2008 @ 6:21PMScientists have used human cells to grow new blood vessels in a mouse for the first time, a US journal reports.
Stem Cell Therapy For Dogs? Wednesday, July 16, 2008 @ 6:02PMStems cells are the breakthrough technology helping people with everything from paralysis to heart disease. Now, a new stem cell therapy is giving relief to dogs and could soon help people suffering from chronic pain
Stem Cell Researchers At UM Enrolling Patients In Heart Failure Study - Catheter Injection System To Be Used Wednesday, July 16, 2008 @ 6:15AMStem cell researchers at the University of Miami Miller School of Medicine are ready to enroll patients in another breakthrough study aimed at treating heart failure. They have received approval from the Food and Drug Administration for a study using a Helical Infusion catheter system to inject stem cells into the heart.
Researchers Uncover Health Benefits Of Aspirin In The Prevention And Treatment Of Osteoporosis Thursday, July 10, 2008 @ 4:19AMResearchers at the University of Southern California, School of Dentistry have uncovered the health benefits of aspirin in the fight against osteoporosis. Forty-four million Americans, 68 percent of whom are women, suffer from the debilitating effects of osteoporosis according to the National Institute of Health.
Researchers uncover benefits of aspirin for treating osteoporosis Wednesday, July 9, 2008 @ 10:09AMResearchers at the University of Southern California, School of Dentistry have uncovered the health benefits of aspirin in the fight against osteoporosis. Forty-four million Americans, 68 percent of whom are women, suffer from the debilitating effects of osteoporosis according to the National Institute of Health. One out of every two women and one in four men over 50 will have an ...
Benefits Of Aspirin For Treating Osteoporosis Uncovered Wednesday, July 9, 2008 @ 9:21AMResearchers have uncovered the health benefits of aspirin in the fight against osteoporosis. The drug appears to prevent both improper bone resorption and the death of bone-forming stem cells.
Researchers Uncover Health Benefits of Aspirin In The Prevention And Treatment Of Osteoporosis Wednesday, July 9, 2008 @ 8:25AMResearchers at the University of Southern California, School of Dentistry have uncovered the health benefits of aspirin in the fight against osteoporosis.
Graduates honored with 2008 Firestone, Golden medals, and new Kennedy Prize Wednesday, July 9, 2008 @ 3:17AMForty-five students were recognized last month with the Firestone Medal for Excellence in Undergraduate Research or the Robert M. Golden Medal for Excellence in the Humanities and Creative Arts. Five of the honorees also were awarded the David M. Kennedy Honors Thesis Prize, which was presented for the first time this year.
Gene directs stem cells to build the heart Wednesday, July 2, 2008 @ 1:31PMJuly 2, 2008 -- Researchers have shown that they can put mouse embryonic stem cells to work building the heart, potentially moving medical science a significant step closer to a new generation of heart disease treatments that use human stem cells.
Osiris Therapeutics Announces 2 Million Dollars Milestone Payment For Clinical Progress Of A Stem Cell Therapy For ... Friday, June 27, 2008 @ 5:13AMOsiris Therapeutics, Inc. (NASDAQ:OSIR) announced that it has achieved $2 million in milestone payments from the Juvenile Diabetes Research Foundation (JDRF) for progress made on a Phase II clinical trial evaluating Prochymal, a mesenchymal stem cell (MSC) therapy, for patients recently diagnosed with type 1 diabetes.
Mesoblast Limited (ASX:MSB) - Strong Progress Continues With Adult Stem Cell Therapy in Several Applications Wednesday, June 25, 2008 @ 2:06AMMelbourne, Australia, June 25, 2008 - (ABN Newswire) - According to the June edition of Bioshares, Mesoblast Limited (ASX:MSB)(USOTC:MBLTY)(PINK:MEOBF) has made exceptionally good progress with its adult stem cell therapy in several applications. "The company has a well-constructed business plan that is positioning the company to deliver on multiple licensing opportunities.
Stem cell treatment in clinical trial at Texas Heart Institute Tuesday, June 24, 2008 @ 1:28PMPhysician scientists at the Texas Heart Institute (THI) at St. Luke’s Episcopal Hospital announced they have begun the world’s first clinical trial to treat heart attack patients with a special type of stem cell to promote better healing and to prevent congestive heart failure, which many patients develop following a heart attack....
Mesenchymal Stem Cells: A Therapeutic Treatment For Severe And Acute Graft-Versus-Host Disease Monday, June 23, 2008 @ 4:12PMA phase II multicenter study performed within the European Group for Blood and Marrow Transplantation (EBMT) Mesenchymal Stem Cell Expansion Consortium, shows that mesenchymal stem cells provide a therapeutic potential for the treatment of acute steroid-refractory GvHD (graft-versus-host disease).
New stem cell tracking technology created Thursday, June 19, 2008 @ 10:39AMU.S. medical researchers say a new stem cell tracking technology might lead to major advances in the use of stem cell therapies to treat cancer.The Stanford University researchers are using non-invasive molecular imaging technology to track the location and activity of mesenchymal stem cells, or MSCs, in the tumors of living organisms.Stem cell cancer therapies are still in the early stages of ...
Text size Thursday, June 19, 2008 @ 4:48AMRegenerative medicine has a major new player following the merger of two of Cambridge’s leading innovators, NovaThera and MedCell Bioscience.
Adult Stem Cells Aid Fracture Healing; Study Lays Groundwork for Potential Treatments Monday, June 16, 2008 @ 12:29PMIn an approach that could become a new treatment for the 10 to 20 percent of people whose broken bones fail to heal, researchers at the University of North Carolina at Chapel Hill have shown that transplantation of adult stem cells can improve healing of fractures.
Pluristem to Exhibit and Present at the BIO International Convention Monday, June 16, 2008 @ 9:22AMPluristem Therapeutics Inc. (NASDAQ:PSTI) (DAX:PJT), a bio-therapeutics company dedicated to the commercialization of non-personalized (allogeneic) cell therapy products for a variety of degenerative, ischemic and autoimmune indications, today announced that the Company will be exhibiting and presenting at the BIO International Convention held in San Diego, California, June 17-20, 2008 (Booth ...
Pluristem to Exhibit and Present at the BIO International Convention Monday, June 16, 2008 @ 9:00AM NEW YORK----Pluristem Therapeutics Inc. , a bio-therapeutics company dedicated to the commercialization of non-personalized cell therapy products for a variety of degenerative, ischemic and autoimmune indications, today announced that the Company will be exhibiting and presenting at the BIO International Convention held in San Diego, California, June 17-20, 2008 .
Cell Factories Sunday, June 1, 2008 @ 5:05AMTraining stem cells to produce what the body is missing.
Stempeutics begins trial on dilated cardiomyopathy Friday, May 30, 2008 @ 9:39PMStempeutics has started an experimental safety and feasibility study in dilated cardiomyopathy patients with no option treatment using mesenchymal stem cells at Manipal Hospital in Bangalore and Kasturba Medical College, Manipal.
Covalon Achieves Another Important Preclinical Milestone in Its EPAS-1 Research Project for Treating Congestive Heart ... Wednesday, May 28, 2008 @ 6:00AM Covalon Technologies Ltd. is pleased to announce that it has successfully achieved another important preclinical milestone in its most significant research project, code-named EPAS-1.
Invitrogen introduces serum free media for stem cells Friday, May 23, 2008 @ 8:28PMInvitrogen has launched a serum free media designed specifically to culture mesenchymal stem cells, or stem cells derived from bone marrow.
Osiris Therapeutics Initiates Phase II Clinical Trial Evaluating Prochymal(TM) For Chronic Obstructive Pulmonary Disease Friday, May 23, 2008 @ 4:10AMOsiris Therapeutics, Inc. (NASDAQ:OSIR) announced the treatment of the first patients in a new Phase II clinical trial evaluating Prochymal, a mesenchymal stem cell (MSC) therapy, for moderate to severe Chronic Obstructive Pulmonary Disease (COPD). This trial marks the sixth indication for which Prochymal has been advanced into Phase II or later-stage clinical trials.
The Global Orthobiologics Market - Players, Products and Technologies Driving Change 2008 Wednesday, May 21, 2008 @ 10:28AM DUBLIN, Ireland----Research and Markets has announced the addition of "The Global Orthobiologics Market - Players, products and technologies driving change 2008" to their offering.
Osiris Therapeutics Initiates Phase II Clinical Trial Evaluating Prochymal(TM) for Chronic Obstructive Pulmonary Disease Wednesday, May 21, 2008 @ 6:15AMOsiris Therapeutics, Inc. (NASDAQ:OSIR) today announced the treatment of the first patients in a new Phase II clinical trial evaluating Prochymal, a mesenchymal stem cell (MSC) therapy, for moderate to severe Chronic Obstructive Pulmonary Disease (COPD). This trial marks the sixth indication for which Prochymal has been advanced into Phase II or later-stage clinical trials.
Osiris Therapeutics Initiates Phase II Clinical Trial Evaluating Prochymal(TM) for Chronic Obstructive Pulmonary Disease Wednesday, May 21, 2008 @ 6:00AM COLUMBIA, Md.----Osiris Therapeutics, Inc. today announced the treatment of the first patients in a new Phase II clinical trial evaluating Prochymal, a mesenchymal stem cell therapy, for moderate to severe Chronic Obstructive Pulmonary Disease .